{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:41:06Z","timestamp":1770061266208,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bmcl.2017.04.021","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T00:16:39Z","timestamp":1491610599000},"page":"2384-2388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension"],"prefix":"10.1016","volume":"27","author":[{"given":"Scott B.","family":"Hoyt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"London","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feroze","family":"Ujjainwalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Tata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Struthers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Cully","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Wisniewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene","family":"Bopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Verras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"McMasters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino","family":"Salituro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Clemas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaochao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"MacNeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2017.04.021_b0005","series-title":"Hypertension Among Adults in the US: National Health and Nutrition Examination Survey, 2011\u20132012. NCHS Data Brief, No. 133","author":"Nwankwo","year":"2013"},{"key":"10.1016\/j.bmcl.2017.04.021_b0010","first-page":"e29","article-title":"Executive summary: heart disease and stroke statistics \u2013 2015 update","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.bmcl.2017.04.021_b0015","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.bmcl.2017.04.021_b0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrendo.2009.263","article-title":"Aldosterone and arterial hypertension","volume":"6","author":"Tomaschitz","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bmcl.2017.04.021_b0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MED.0b013e3283390fa4","article-title":"Aldosterone and cardiovascular disease","volume":"17","author":"Carey","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.bmcl.2017.04.021_b0030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ki.2011.505","article-title":"Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms","volume":"81","author":"Shavit","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.bmcl.2017.04.021_b0035","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1021\/jm401430e","article-title":"Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases","volume":"57","author":"Hu","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.04.021_b0040","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2174\/1568026611313120003","article-title":"Progress toward clinically useful aldosterone synthase inhibitors","volume":"13","author":"Cerny","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmcl.2017.04.021_b0045","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1021\/acsmedchemlett.5b00054","article-title":"Discovery of benzimidazole CYP11B2 inhibitors with in Vivo activity in rhesus monkeys","volume":"6","author":"Hoyt","year":"2015","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.04.021_b0050","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1021\/acsmedchemlett.5b00048","article-title":"Discovery of triazole CYP11B2 inhibitors with in Vivo activity in rhesus monkeys","volume":"6","author":"Hoyt","year":"2015","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.04.021_b0055","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1021\/acs.jmedchem.5b00079","article-title":"Novel pyridyl substituted 4,5-dihydro-[1,2,4]-triazolo[4,3-a]quinolines as potent and selective aldosterone synthase inhibitors with improved in vitro metabolic stability","volume":"58","author":"Hu","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.04.021_b0060","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ejmech.2014.12.022","article-title":"Heteroatom insertion into 3,4-dihydro-1H-quinolin-2-ones leads to potent and selective inhibitors of human and rat aldosterone synthase","volume":"90","author":"Grombein","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2017.04.021_b0065","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1021\/jm500140c","volume":"57","author":"Yin","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.04.021_b0070","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1021\/ml400324c","article-title":"Discovery and in vivo evaluation of potent dual CYP11B2 (aldosterone synthase) and CYP11B1 inhibitors","volume":"4","author":"Meredith","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.04.021_b0075","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1021\/acs.jmedchem.5b00407","article-title":"Structure-activity relationships, pharmacokinetics, and in vivo activity of CYP11B2 and CYP11B1 inhibitors","volume":"58","author":"Papillon","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.04.021_b0080","doi-asserted-by":"crossref","first-page":"9382","DOI":"10.1021\/acs.jmedchem.5b01545","article-title":"Discovery of N-[5-(6-chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-ethanesulfonamide, a cortisol-sparing CYP11B2 inhibitor that lowers aldosterone in human subjects","volume":"58","author":"Papillon","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.04.021_b0085","doi-asserted-by":"crossref","first-page":"8054","DOI":"10.1021\/acs.jmedchem.5b00851","article-title":"Discovery of 4-Aryl-5,6,7,8-tetrahydroisoquinolines as potent, selective, and orally active aldosterone synthase (CYP11B2) inhibitors: in vivo evaluation in rodents and cynomologous monkeys","volume":"58","author":"Martin","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.04.021_b0090","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.111.029892","article-title":"Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension","volume":"124","author":"Calhoun","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bmcl.2017.04.021_b0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ndt\/gfs388","article-title":"Aldosterone synthase inhibition in humans","volume":"28","author":"Azizi","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bmcl.2017.04.021_b0100","unstructured":"Ali A, Bennett DJ, Cai J, et al. Imidazopyridyl Compounds as Aldosterone Synthase Inhibitors. US 9173873, 11\/3\/2015."},{"key":"10.1016\/j.bmcl.2017.04.021_b0105","unstructured":"Bennett DJ, Cai J, Carswell E, et al. Pyrazolopyridyl Compounds as Aldosterone Synthase Inhibitors. US 9351973, 5\/31\/2016."},{"key":"10.1016\/j.bmcl.2017.04.021_b0110","unstructured":"Bennett DJ, Cai J, Carswell E, et al. Compounds as Aldosterone Synthase Inhibitors. US 9193724, 11\/24\/2015."},{"key":"10.1016\/j.bmcl.2017.04.021_b0115","unstructured":"Hoyt SB, Taylor J, London C, Xiong Y, Cooke A. Indazole Compounds as Aldosterone Synthase Inhibitors. WO 2014099833, 6\/26\/2014."},{"key":"10.1016\/j.bmcl.2017.04.021_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmcl.2017.04.021_b0125","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.04.021_b0130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/jm701122q","article-title":"Generation of a set of simple, interpretable ADMET rules of thumb","volume":"51","author":"Gleeson","year":"2008","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17303840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17303840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:20:32Z","timestamp":1760772032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X17303840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0960894X17303840"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.04.021","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}